Plasma interleukin-18 reflects severity of ulcerative colitis

被引:27
作者
Wiercinska-Drapalo, Alicja [1 ]
Flisiak, Robert [1 ]
Jaroszewicz, Jerzy [1 ]
Prokopowicz, Danuta [1 ]
机构
[1] Med Univ Bialystok, Intestinal Dis Unit, Dept Infect Dis, PL-15540 Bialystok, Poland
关键词
Ulcerative colitis; Interleukin-18;
D O I
10.3748/wjg.v11.i4.605
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: The aim of this study was to evaluate the association between ulcerative colitis activity and plasma or mucosal concentrations of interleukin (IL)-18. METHODS: Il-18 concentrations were measured in plasma and mucosal samples from 15 patients with active ulcerative colitis (UC). RESULTS: The mean plasma concentration of IL-18 measured in all patients (422 +/- 88 pg/mL) doubled the mean value in healthy controls (206 +/- 32 pg/mL); however, the difference was not statistically significant. Plasma IL-18 levels revealed a significant positive correlation with scored endoscopic degree of mucosal injury, disease activity index, clinical activity index and C-reactive protein concentration. The mean concentration of plasma IL-18 was significantly higher in patients with severe ulcerative colitis (535 +/- 115 pg/mL) than in patients with mild ulcerative colitis (195 +/- 41 pg/mL), and in healthy controls. Although the mucosal mean IL-18 concentration in severe ulcerative colitis (2 523 +/- 618 pg/mg protein) doubled values observed in mild one (1 347 +/- 308 pg/mg protein), there was no statistically significant difference. CONCLUSION: Plasma IL-18 can be considered as a surrogate marker helpful in evaluation of ulcerative colitis activity. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:605 / 608
页数:4
相关论文
共 25 条
[1]   Growth factors in inflammatory bowel disease [J].
Beck, PL ;
Podolsky, DK .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (01) :44-60
[2]   IL-1β and TNF-α, but not IFN-α, IFN-γ, IL-6 or IL-8, are secretory mediators in human distal colon [J].
Bode, H ;
Schmitz, H ;
Fromm, M ;
Scholz, P ;
Riecken, EO ;
Schulzke, JD .
CYTOKINE, 1998, 10 (06) :457-465
[3]   Inflammatory bowel disease: Etiology and pathogenesis [J].
Fiocchi, C .
GASTROENTEROLOGY, 1998, 115 (01) :182-205
[4]   Serum interleukin-18 concentrations in patients with inflammatory bowel disease [J].
Furuya, D ;
Yagihashi, A ;
Komatsu, M ;
Masashi, N ;
Tsuji, N ;
Kobayashi, D ;
Watanabe, N .
JOURNAL OF IMMUNOTHERAPY, 2002, 25 :S65-S67
[5]   Cutting edge: IL-18-transgenic mice: In vivo evidence of a broad role for IL-18 in modulating immune function [J].
Hoshino, T ;
Kawase, Y ;
Okamoto, M ;
Yokota, K ;
Yoshino, K ;
Yamamura, K ;
Miyazaki, J ;
Young, HA ;
Oizumi, K .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7014-7018
[6]  
Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO
[7]  
2-U
[8]   Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice [J].
Ishikura, T ;
Kanai, T ;
Uraushihara, K ;
Iiyama, R ;
Makita, S ;
Totsuka, T ;
Yamazaki, M ;
Sawada, T ;
Nakamura, T ;
Miyata, T ;
Kitahora, T ;
Hibi, T ;
Hoshino, T ;
Watanabe, M .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (08) :960-969
[9]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[10]   Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis [J].
Matsuzaki, K ;
Hokari, R ;
Kato, S ;
Tsuzuki, Y ;
Tanaka, H ;
Kurihara, C ;
Iwai, A ;
Kawaguchi, A ;
Nagao, S ;
Itoh, K ;
Nagata, K ;
Miura, S .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) :1081-1088